BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 6465831)

  • 1. Prostatic acid phosphatase: clinical utility in detection, assessment, and monitoring carcinoma of the prostate.
    Pappas AA; Gadsden RH
    Ann Clin Lab Sci; 1984; 14(4):285-91. PubMed ID: 6465831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the radioimmunoassay for prostatic acid phosphatase in prostatic carcinoma.
    Bruce AW; Mahan DE; Belville WD
    Urol Clin North Am; 1980 Oct; 7(3):645-52. PubMed ID: 7456177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The laboratory diagnosis of prostatic adenocarcinoma.
    Griffiths JC
    Crit Rev Clin Lab Sci; 1983; 19(3):187-204. PubMed ID: 6144453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of acid phosphatase in prostatic carcinoma].
    Bauer HW; Walther V; Schmiedt F
    Fortschr Med; 1980 Sep; 98(34):1301-5. PubMed ID: 7461538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Cancer Res; 1981 Mar; 41(3):1180-3. PubMed ID: 7459859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF
    Urol Clin North Am; 1980 Oct; 7(3):653-65. PubMed ID: 6161460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A solid-phase radioimmunoassay for human prostatic acid phosphatase.
    Foti AG; Herschman H; Cooper JF
    Cancer Res; 1975 Sep; 35(9):2446-52. PubMed ID: 1170944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
    Zweig MH; Ihde DC
    Cancer Res; 1985 Aug; 45(8):3945-50. PubMed ID: 3893691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
    Cooper EH; Bauer HW; Dati F
    Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioimmunoassay for prostatic acid phosphatase.
    Cooper JF; Foti AG
    Natl Cancer Inst Monogr; 1978 Dec; (49):235-7. PubMed ID: 748776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of prostatic acid phosphatase in various cell lines.
    Foti AG; Herschman H; Cooper JF
    Natl Cancer Inst Monogr; 1978 Dec; (49):55-6. PubMed ID: 571048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostatic cancer. Reliability of clinical staging and the prognostic significance of age, clinical stage and tumor morphology].
    Mihatsch MJ; Rist M; Ohnacker H; Oberholzer M; Spichtin HP; Schmassmann A; Perret A; Torhorst J; Rutishauser G
    Z Urol Nephrol; 1983 May; 76(5):281-97. PubMed ID: 6880416
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunoassay of prostatic acid phosphatase in carcinoma of the prostate.
    N Engl J Med; 1978 Apr; 298(16):912-3. PubMed ID: 634336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma.
    Bentz MS; Cohen C; Demers LM; Budgeon LR
    Arch Pathol Lab Med; 1982 Sep; 106(9):476-80. PubMed ID: 6287961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y; Wang MC; Chu TM
    Urol Clin North Am; 1984 May; 11(2):269-76. PubMed ID: 6203206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.